Skip to content

PositiveLinks for Youth (PL4Y) for Texas

PositiveLinks for Youth (PL4Y) for Texas: Effectiveness, Feasibility, and Acceptability of mHealth to Improve Care Outcomes for Young Adults With HIV

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07804602
Enrollment
600
Registered
2026-09-04
Start date
2027-04-01
Completion date
2031-04-01
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, Human Immunodeficiency Virus

Keywords

Communication with providers, Smartphone App, Anonymous Virtual chat group, Medication reminders

Brief summary

The goal of this interventional clinical trial is to test an an app, PL4Y, installed on a mobile smartphone to see if it can help participants aged 18-29 years who have HIV achieve success with their HIV care and feel supported by their clinic community. The first 6 months will be standard of care, after which participants will continue to meet virtually with their health care providers and will also be provided with and taught how to use the app. The standard of care clinic visits will continue as before and virtual visits using the app will be started and continue for abot 18 months. Adherence to medications Appointment reminders Provide secure communication with providers Provide a support group in \[describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers\]. The main question\[s\] it aims to answer \[is/are\]: \[primary hypothesis or outcome measure 1\]? \[primary hypothesis or outcome measure 2\]? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\]. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Detailed description

The overall objective of this proposal is to implement and rigorously test an existing mHealth care engagement intervention, PL4Y, in a six clinic network in Texas. The investigators will use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to inform a type 1 hybrid study, assessing effectiveness of PL4Y alongside measures of acceptability, feasibility, and sustainability. The study has two main components: * A cluster randomized longitudinal staircase trial across six clinics in Texas * Qualitative assessment, using semi-structured interviews and focus groups, of acceptability and feasibility of PL4Y implementation in the clinics

Interventions

BEHAVIORALPositiveLinks for Youth Smartphone App

PL4Y, a smartphone application (app), is a clinic-based multimodal intervention designed by and for youth living with HIV, including daily adherence assessment, appointment reminders, secure messaging with clinic providers, and an asynchronous, anonymized virtual support group.

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER
National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Type 1 hybrid study. Staircase design is a particular variation of the incomplete stepped-wedge design.It allows for phased implementation of the intervention across all participating clusters in a staggered fashion, ensuring all clusters receive the intervention. A cluster serves both as its control, as it spends time under both control and intervention conditions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

1. 18-29yo living with HIV 2. Attending at least one in-person visit in the clinic site of enrollment in the past 12 mos, 3. English speaking 4. Able to participate in the informed consent process. 5. Access to a personal smartphone with a data plan capable of supporting the PL4Y app. The phone must be password protected and not shared with others for confidentiality purposes. 6. Interviews only- A stakeholder in one of the network clinics 1. 18 years or older 2. able to participate in the informed consent process

Exclusion criteria

1. They cannot provide consent 2. Unwilling or unable to complete virtual study visits

Design outcomes

Primary

MeasureTime frameDescription
Virologic SuppressionBaseline to 12 months (+/- 3 months)HIV-1 Plasma RNA level \<200 copies/ml at 12 months

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-9 (PHQ-9)Baseline to Study End (approximately 18 months)A 9 item survey with each item scored: 0: Not at all 1: Several days 2: More than half the days 3: Nearly every day Total possible score is between 0-27, with a higher score indicating more symptoms indicative of depression
HIV Stigma Scale Survey (HIVSS)Baseline to Study End (approximately 18 months)A 40 item scale, with each item scored from 1=Strongly agree, 2=Disagree, 3=Agree, 4=Strongly agree. The total score can range from 10-40 with a higher score indicating more stigma
National Institute of Drug Abuse (NIDA) - Modified ASSISTBaseline to study end (approximately 18 months)A quick screen questionnaire that includes only Question 2 of the NIDA-modified ASSIST regarding substance abuse. 10 substances are included and each is scored depending on use: Never=0, Once or Twice=2, Monthly=3, Weekly=4, Daily or Almost daily = 6. Total scores range from 0-60 with a higher score indicating more frequent substance abuse.
System Usability SurveyMonth 12 and Month 18This survey is administered at Visits 2 and 3 with 10 structured questions scored from 0=Strongly Disagree, 1=Disagree, 2=Somewhat Disagree, 4=Neither Agree nor Disagree, 5=Somewhat Agree, 6=Agree, 7=Strongly Agree. There are 3 additional free response questions that are not scored. Total scores range from 0-70 with a higher score indicating better system usability.
HIV Care EngagementBaseline through end of study, measured at each study time point (baseline, 6mos, 12 mos, 18 mos)At least two clinic visits \>60 days apart in the prior 12 months

Countries

United States

Contacts

CONTACTBarbara Taylor, MD, MS
taylorb4@uthscsa.edu210-450-8144
CONTACTCyrena Cote
cotec@uthscsa.edu210-450-7277
PRINCIPAL_INVESTIGATORBarbara Taylor, MD, MS

The University of Texas Health Science Center at San Antonio

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026